Congress Should Act ‘Quickly’ On Female Genital Mutilation Bill, New York Times Editorial States

In an editorial, the New York Times calls on Congress to “move quickly” to pass the Girls Protection Act (HR 5137), which would “make it a felony to take a girl out of the country” to undergo female genital mutilation. The U.S…

Videos Feature Supreme Court Confirmation Hearings, Interview With GOP Sen. Candidate

The following summarizes selected women’s health related videos.  Kagan Discusses Abortion Rights: Sen. Dianne Feinstein (D-Calif.) became the first lawmaker to raise the issue of abortion rights during Supreme Court nominee Elena Kagan’s Senate Judiciary Committee confirmation hearing this week…

Physical Activity In Teens Reduces Risk Of Cognitive Impairment In Later Life

Women who are physically active at any point over the life course (teenage, age 30, age 50, late life) have lower risk of cognitive impairment in late-life compared to those who are inactive, but teenage physical activity appears to be most important. This is the key finding of a study of over nine thousand women [...]

CMS Considers Payment Policy for Provenge

WASHINGTON (MedPage Today) — The Centers for Medicare and Medicaid Services announced it has started the process of deciding whether to cover the costly prostate cancer immunotherapeutic agent sipuleucel-T (Provenge).

Conflicts-of-Interest Form Modified

The International Committee of Medical Journal Editors (ICMJE) has tweaked its uniform financial disclosure form.

New Website Evaluates Stem Cell Claims

Patients seeking stem cell treatments for various conditions now have an online resource to help them evaluate the claims of clinics and companies around the world.

ThromboGenics to present microplasmin Phase III trial data at 28th ASRS and 10th EURETINA Congress

ThromboGenics NV, a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, announces that data from the second Phase III trial of microplasmin (TG-MV-007) for the non-surgical treatment of vitreomacular adhesion (VMA), are to be presented at the 28th Annual Meeting of the American Society of Retina Specialists (ASRS) and [...]

Studies on VIAject and Vialog presented at 70th American Diabetes Association sessions

Studies of a more-rapid-acting injectable human insulin formulation (VIAject®) in the treatment of type 1 and type 2 diabetes and of a novel insulin analog formulation (Vialog™) in an animal model of diabetes were reported this week in three poster presentations at the 70th Scientific Sessions of the American Diabetes Association in Orlando, Florida. [...]

Oxycyte PFCE decreases mortality after onset of decompression sickness in porcine model study

Oxygen Biotherapeutics, Inc. today announced that results from U.S. Navy studies demonstrated decreased mortality in porcine animal models that were given an intravenous dose of Oxycyte® perfluorocarbon emulsion (PFCE) after the onset of decompression sickness (DCS). These results showed a statistically significant decrease in mortality compared with the control group that did not receive Oxycyte [...]

Study results of triple combination therapy in patients with diabetes and hypertension presented at ADA 2010

Preliminary results of a pre-specified subgroup study analysis of patients with diabetes and hypertension demonstrated that the investigational triple combination therapy of olmesartan medoxomil / amlodipine / hydrochlorothiazide (40/10/25 mg) resulted in a statistically significant greater Least Squares mean reduction in blood pressure from baseline at week 12 (37.9/22.0 mm Hg versus 26.4-28.0/14.7-17.6 mm Hg, [...]